On May, 1 Analysts See $0.03 EPS for CryoLife, Inc. (CRY)

CryoLife, Inc. (NYSE:CRY) Corporate Logo
During Q4 2018 the big money sentiment increased to 1.75. That’s change of 0.64, from 2018Q3’s 1.11. 13 investors sold all, 31 reduced holdings as CryoLife, Inc. ratio improved. 48 rose holdings while 29 funds amassed holdings. Funds hold 26.14 million shares thus 2.28% more from 2018Q3’s 25.56 million shares.
Swiss Bancshares holds 0% or 58,500 shs. Elk Creek Prns Ltd Liability Corporation reported 0.61% of its capital in CryoLife, Inc. (NYSE:CRY). 12,917 were accumulated by Barclays Public Limited Com. California State Teachers Retirement holds 0% or 55,712 shs in its capital. Moreover, Dimensional Fund Advsr Limited Partnership has 0.02% invested in CryoLife, Inc. (NYSE:CRY) for 1.93M shs. Teachers Retirement Of The State Of Kentucky owns 8,173 shs. Cap Research Glob Investors invested 0.02% of its capital in CryoLife, Inc. (NYSE:CRY). Manufacturers Life Insur The holds 0% of its capital in CryoLife, Inc. (NYSE:CRY) for 21,555 shs. Comml Bank Of America Corporation De stated it has 123,223 shs. Ubs Asset Management Americas Inc accumulated 12,179 shs. Us National Bank & Trust De reported 0% of its capital in CryoLife, Inc. (NYSE:CRY). Goldman Sachs Grp Inc accumulated 112,218 shs. Rhumbline Advisers invested in 0.01% or 99,844 shs. Janney Montgomery Scott Limited Liability invested 0.02% of its capital in CryoLife, Inc. (NYSE:CRY). Aqr Cap Management Limited holds 0% of its capital in CryoLife, Inc. (NYSE:CRY) for 13,209 shs.

CryoLife, Inc. (NYSE:CRY)’s earnings release is anticipated by WallStreet on May, 1, according to RTT. Last year’s EPS was $0.02, while now analysts expect change of 50.00 % up from current $0.03 EPS. If CRY’s EPS is $0.03 the profit will be $1.11M for 247.83 P/E. -40.00 % negative EPS growth is what Wall Street’s predicts after $0.05 reported EPS last quarter. The last price was $29.74.It’s uptrending since April 8, 2018 and is 57.61% up. CRY outperformed the S&P500 by 53.24%.

CryoLife, Inc., together with its subsidiaries, makes and distributes medical devices worldwide.The firm is valued at $1.10 billion. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries.Last it reported negative earnings. The firm operates in two divisions, Medical Devices and Preservation Services.

For more CryoLife, Inc. (NYSE:CRY) news brought out briefly go to: Seekingalpha.com, Fool.com, Investorplace.com, Barrons.com or Zacks.com. The titles are as follows: “Cowen likes managed care firms in premarket analyst action – Seeking Alpha” brought out on February 28, 2019, “Will Boeing’s Problems Spell Trouble for GE Aviation? – The Motley Fool” on March 20, 2019, “A Pair of Semiconductor Stock Buys: AMD and Micron – Investorplace.com” with a publish date: April 04, 2019, “What No One Is Talking About in GE’s Turnaround – Barron’s” and the last “Cryolife (CRY) Earnings Miss, Revenues Top Estimates in Q4 – Zacks.com” with publication date: February 18, 2019.

CryoLife, Inc. (NYSE:CRY) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.